Iovance Biotherapeutics's total assets for Q2 2025 were $907.44M, a decrease of -6.13% from the previous quarter. IOVA total liabilities were $208.95M for the fiscal quarter, a 5.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.